214 related articles for article (PubMed ID: 21864238)
1. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
Lima JC; Rodriguez L
Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
[TBL] [Abstract][Full Text] [Related]
2. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
[TBL] [Abstract][Full Text] [Related]
3. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
[TBL] [Abstract][Full Text] [Related]
5. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
6. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Gold derivatives as anti-cancer agents.
Raurell LR
Anticancer Agents Med Chem; 2011 Dec; 11(10):920. PubMed ID: 22023049
[No Abstract] [Full Text] [Related]
9. Anticancer Agents: Does a Phosphonium Behave Like a Gold(I) Phosphine Complex? Let a "Smart" Probe Answer!
Ali M; Dondaine L; Adolle A; Sampaio C; Chotard F; Richard P; Denat F; Bettaieb A; Le Gendre P; Laurens V; Goze C; Paul C; Bodio E
J Med Chem; 2015 Jun; 58(11):4521-8. PubMed ID: 25973667
[TBL] [Abstract][Full Text] [Related]
10. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
Liu JJ; Galettis P; Farr A; Maharaj L; Samarasinha H; McGechan AC; Baguley BC; Bowen RJ; Berners-Price SJ; McKeage MJ
J Inorg Biochem; 2008 Feb; 102(2):303-10. PubMed ID: 18029019
[TBL] [Abstract][Full Text] [Related]
11. Chemical biology of anticancer gold(III) and gold(I) complexes.
Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the biological evaluation of gold anticancer agents.
Fricker SP
Anticancer Agents Med Chem; 2011 Dec; 11(10):940-52. PubMed ID: 21864236
[TBL] [Abstract][Full Text] [Related]
13. Potent and Selective Cytotoxic and Anti-inflammatory Gold(III) Compounds Containing Cyclometalated Phosphine Sulfide Ligands.
Reddy TS; Pooja D; Privér SH; Luwor RB; Mirzadeh N; Ramesan S; Ramakrishna S; Karri S; Kuncha M; Bhargava SK
Chemistry; 2019 Nov; 25(62):14089-14100. PubMed ID: 31414501
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
15. Gold(III) complexes in medicinal chemistry.
Maia PI; Deflon VM; Abram U
Future Med Chem; 2014 Sep; 6(13):1515-36. PubMed ID: 25365235
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
Casini A; Messori L
Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
[TBL] [Abstract][Full Text] [Related]
17. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
18. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
19. Structure and redox stability of [Au(III)(X^N^X)PR
Sánchez Delgado GY; Paschoal D; de Oliveira MAL; Dos Santos HF
J Inorg Biochem; 2019 Nov; 200():110804. PubMed ID: 31472435
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
